RESTASIS – pharmaceutical daily

December 9, 2016 Off

Allergan dissapointed with PTAB’s reaction as Mylan petitions for IPR of Restasis patents

Allergan said on Thursday that it was disappointed in the PTAB’s decision to institute IPR proceedings regarding the patents that…

October 31, 2016 Off

Allergan’s chronic dry eye drops will make patients shed more tears

By Dino Mustafić

Allergan has received approval from the FDA for Restasis, treatment to help patients with a type of Chronic Dry Eye …

November 11, 2015 Off

Allergan submits Prior Approval Supplement for RESTASIS

By Dino Mustafić

Allergan has submitted a Prior Approval Supplement (PAS) for RESTASIS (Cyclosporine Ophthalmic Emulsion) 0.05%, seeking approval of a Multi-Dose Preservative-Free (MDPF) presentation.